Matches in SemOpenAlex for { <https://semopenalex.org/work/W3176196950> ?p ?o ?g. }
- W3176196950 endingPage "2931" @default.
- W3176196950 startingPage "2917" @default.
- W3176196950 abstract "Boosting NAD+ via supplementation with niacin equivalents has been proposed as a potential modality capable of promoting healthy aging and negating age-dependent declines of skeletal muscle mass and function.We investigated the efficacy of NAD+-precursor supplementation (tryptophan, nicotinic acid, and nicotinamide) on skeletal muscle mitochondrial function in physically compromised older adults.A randomized, double-blind, controlled trial was conducted in 14 (female/male: 4/10) community-dwelling, older adults with impaired physical function [age, 72.9 ± 4.0 years; BMI, 25.2 ± 2.3 kg/m2]. Participants were supplemented with 207.5 mg niacin equivalents/day [intervention (INT)] and a control product (CON) that did not contain niacin equivalents, each for 32 days. The primary outcomes tested were mitochondrial oxidative capacity and exercise efficiency, analyzed by means of paired Student's t-tests. Secondary outcomes, such as NAD+ concentrations, were analyzed accordingly.Following supplementation, skeletal muscle NAD+ concentrations [7.5 ± 1.9 compared with 7.9 ± 1.6 AU, respectively] in INT compared with CON conditions were not significantly different compared to the control condition, whereas skeletal muscle methyl-nicotinamide levels were significantly higher under NAD+-precursor supplementation [INT, 0.098 ± 0.063 compared with CON, 0.025 ± 0.014; P = 0.001], suggesting an increased NAD+ metabolism. Conversely, neither ADP-stimulated [INT, 82.1 ± 19.0 compared with CON, 84.0 ± 19.2; P = 0.716] nor maximally uncoupled mitochondrial respiration [INT, 103.4 ± 30.7 compared with CON, 108.7 ± 33.4; P = 0.495] improved under NAD+-precursor supplementation, nor did net exercise efficiency during the submaximal cycling test [INT, 20.2 ± 2.77 compared with CON, 20.8 ± 2.88; P = 0.342].Our findings are consistent with previous findings on NAD+ efficacy in humans, and we show in community-dwelling, older adults with impaired physical function that NAD+-precursor supplementation through L-tryptophan, nicotinic acid, and nicotinamide does not improve mitochondrial or skeletal muscle function. This study was registered at clinicaltrials.gov as NCT03310034." @default.
- W3176196950 created "2021-07-05" @default.
- W3176196950 creator A5007320210 @default.
- W3176196950 creator A5016480998 @default.
- W3176196950 creator A5022874682 @default.
- W3176196950 creator A5023656528 @default.
- W3176196950 creator A5028784521 @default.
- W3176196950 creator A5030289828 @default.
- W3176196950 creator A5033888562 @default.
- W3176196950 creator A5049502258 @default.
- W3176196950 creator A5049850291 @default.
- W3176196950 creator A5049905804 @default.
- W3176196950 creator A5070391533 @default.
- W3176196950 creator A5071857743 @default.
- W3176196950 creator A5073508425 @default.
- W3176196950 creator A5087038295 @default.
- W3176196950 date "2021-10-01" @default.
- W3176196950 modified "2023-10-16" @default.
- W3176196950 title "NAD+-Precursor Supplementation With L-Tryptophan, Nicotinic Acid, and Nicotinamide Does Not Affect Mitochondrial Function or Skeletal Muscle Function in Physically Compromised Older Adults" @default.
- W3176196950 cites W1584316378 @default.
- W3176196950 cites W1996067821 @default.
- W3176196950 cites W2028178274 @default.
- W3176196950 cites W2030320197 @default.
- W3176196950 cites W2038011036 @default.
- W3176196950 cites W2038085138 @default.
- W3176196950 cites W2038391272 @default.
- W3176196950 cites W2039663806 @default.
- W3176196950 cites W2040281761 @default.
- W3176196950 cites W2041811148 @default.
- W3176196950 cites W2045051842 @default.
- W3176196950 cites W2047898810 @default.
- W3176196950 cites W2054485468 @default.
- W3176196950 cites W2089838011 @default.
- W3176196950 cites W2090442368 @default.
- W3176196950 cites W2091024743 @default.
- W3176196950 cites W2093317259 @default.
- W3176196950 cites W2096657471 @default.
- W3176196950 cites W2097146819 @default.
- W3176196950 cites W2104035332 @default.
- W3176196950 cites W2104750100 @default.
- W3176196950 cites W2111859264 @default.
- W3176196950 cites W2114382609 @default.
- W3176196950 cites W2126525177 @default.
- W3176196950 cites W2129202858 @default.
- W3176196950 cites W2134172979 @default.
- W3176196950 cites W2136868680 @default.
- W3176196950 cites W2142483199 @default.
- W3176196950 cites W2143930443 @default.
- W3176196950 cites W2159212679 @default.
- W3176196950 cites W2165722123 @default.
- W3176196950 cites W2171748049 @default.
- W3176196950 cites W2239653845 @default.
- W3176196950 cites W2343193821 @default.
- W3176196950 cites W2400466055 @default.
- W3176196950 cites W2427895239 @default.
- W3176196950 cites W2465287431 @default.
- W3176196950 cites W2530388030 @default.
- W3176196950 cites W2546015443 @default.
- W3176196950 cites W2620825787 @default.
- W3176196950 cites W2734481251 @default.
- W3176196950 cites W2789621916 @default.
- W3176196950 cites W2795014519 @default.
- W3176196950 cites W2800314655 @default.
- W3176196950 cites W2801147755 @default.
- W3176196950 cites W2827617026 @default.
- W3176196950 cites W2895826492 @default.
- W3176196950 cites W2950596378 @default.
- W3176196950 cites W2950657114 @default.
- W3176196950 cites W2954411572 @default.
- W3176196950 cites W2968217662 @default.
- W3176196950 cites W2984194295 @default.
- W3176196950 cites W2984413344 @default.
- W3176196950 cites W3016629372 @default.
- W3176196950 cites W3022810443 @default.
- W3176196950 cites W3124241418 @default.
- W3176196950 cites W4255692377 @default.
- W3176196950 doi "https://doi.org/10.1093/jn/nxab193" @default.
- W3176196950 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8485915" @default.
- W3176196950 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34191033" @default.
- W3176196950 hasPublicationYear "2021" @default.
- W3176196950 type Work @default.
- W3176196950 sameAs 3176196950 @default.
- W3176196950 citedByCount "11" @default.
- W3176196950 countsByYear W31761969502022 @default.
- W3176196950 countsByYear W31761969502023 @default.
- W3176196950 crossrefType "journal-article" @default.
- W3176196950 hasAuthorship W3176196950A5007320210 @default.
- W3176196950 hasAuthorship W3176196950A5016480998 @default.
- W3176196950 hasAuthorship W3176196950A5022874682 @default.
- W3176196950 hasAuthorship W3176196950A5023656528 @default.
- W3176196950 hasAuthorship W3176196950A5028784521 @default.
- W3176196950 hasAuthorship W3176196950A5030289828 @default.
- W3176196950 hasAuthorship W3176196950A5033888562 @default.
- W3176196950 hasAuthorship W3176196950A5049502258 @default.
- W3176196950 hasAuthorship W3176196950A5049850291 @default.
- W3176196950 hasAuthorship W3176196950A5049905804 @default.
- W3176196950 hasAuthorship W3176196950A5070391533 @default.
- W3176196950 hasAuthorship W3176196950A5071857743 @default.